Literature DB >> 7064175

Outcome of 314 patients with transient ischemic attacks.

A Muuronen, M Kaste.   

Abstract

Between 1967 and 1976, 314 patients with transient ischemic attack (TIA) were evaluated and treated. Follow-up has been from 2.8 to 13.2 years (mean 7.8). As of 1979, 55 of the patients had succumbed to cardiovascular disease (28), cerebrovascular disease (9), malignancy (10), and other causes (8). During the follow-up period, 15 patients suffered brain infarction (4.8% under the risk) while 40 had myocardial infarction (12.7%) under the risk). Brain infarction occurred as often in patients with carotid TIA as in those with vertebral-basilar TIA, and was more common in patients under anticoagulation therapy than in those without it (p less than 0.05). Arterial hypertension, heart disease, peripheral arterial disease and diabetes did not increase the risk of brain infarction, but all (except diabetes) increased the risk of myocardial infarction. Combination of TIA with arterial hypertension, heat disease, or peripheral arterial disease increased the mortality (p less than 0.001). A life table analysis of surviving 1, 5, and 10 years gave probabilities of 99 and 100%, 89 and 91%, and 60 and 75% for males and females respectively. In the case of normotensive and hypertensive patients, a life table analysis of chances of surviving 1, 5, and 10 years gave probabilities of 100 and 95%. 94 and 80%, and 76 and 49% in both groups respectively. The result clearly emphasize treating of arterial hypertension, and demonstrate that TIA is not only a warning sign of impending stroke but also that of myocardial infarction.

Entities:  

Mesh:

Year:  1982        PMID: 7064175     DOI: 10.1161/01.str.13.1.24

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  17 in total

1.  Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events?

Authors:  G J Hankey; J M Slattery; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

2.  Incidence and predictors of myocardial infarction after transient ischemic attack: a population-based study.

Authors:  Joseph D Burns; Alejandro A Rabinstein; Veronique L Roger; Latha G Stead; Teresa J H Christianson; Jill M Killian; Robert D Brown
Journal:  Stroke       Date:  2011-03-24       Impact factor: 7.914

3.  Haemodynamics and oxygen metabolism in patients after reversible ischaemic attack or minor ischaemic stroke assessed with positron emission tomography.

Authors:  M Itoh; J Hatazawa; C Pozzilli; H Fukuda; Y Abe; T Fujiwara; K Kubota; K Yamaguchi; T Sato; H Watanabe
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

Review 4.  Transient ischemic attacks and stroke.

Authors:  T R Mirsen; V C Hachinski
Journal:  CMAJ       Date:  1988-06-15       Impact factor: 8.262

5.  Amaurosis fugax.

Authors:  W Pryse-Phillips
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-16

6.  Transient ischaemic attacks in young patients: a thromboembolic or migrainous manifestation? A 10 year follow up study of 46 patients.

Authors:  B H Larsen; P S Sørensen; J Marquardsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

Review 7.  Clinical evaluation and management of transient ischemic attacks.

Authors:  J F Rothrock
Journal:  West J Med       Date:  1987-04

8.  The prognosis of hospital-referred transient ischaemic attacks.

Authors:  G J Hankey; J M Slattery; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

9.  Distribution of ischemic cerebrovascular events in cardiac embolism.

Authors:  W Oder; P Siostrzonek; W Lang; H Gössinger; H Kollegger; M Zangeneh; K Zeiler; L Deecke
Journal:  Klin Wochenschr       Date:  1991-10-18

10.  Fire-heat and Qi deficiency syndromes as predictors of short-term prognosis of acute ischemic stroke.

Authors:  Shu-Chen Cheng; Chien-Hsiung Lin; Yeu-Jhy Chang; Tsong-Hai Lee; Shan-Jin Ryu; Chun-Hsien Chen; Her-Kun Chang; Chee-Jen Chang; Wen-Long Hu; Yu-Chiang Hung
Journal:  J Altern Complement Med       Date:  2013-04-19       Impact factor: 2.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.